Kitov Pharmaceuticals Holdings Ltd. Sponsored ADR
(NASDAQ : KTOV)

( )
KTOV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.07%140.690.6%$730.85m
ABBVAbbVie, Inc.
4.11%95.962.1%$594.35m
PFEPfizer Inc.
-1.02%35.830.8%$545.75m
MRKMerck & Co., Inc.
0.44%63.500.6%$449.71m
BMYBristol-Myers Squibb Company
-0.75%63.701.4%$321.76m
LLYEli Lilly and Company
-0.35%85.761.0%$268.88m
GSKGlaxoSmithKline plc Sponsored ADR
0.44%41.010.2%$154.32m
AZNAstraZeneca PLC Sponsored ADR
-0.37%34.651.3%$154.27m
NVSNovartis AG Sponsored ADR
-0.30%86.090.2%$134.05m
NVONovo Nordisk A/S Sponsored ADR Class B
1.68%50.140.1%$113.33m
SNYSanofi Sponsored ADR
-0.10%49.540.2%$54.30m
LCILannett Company, Inc.
1.30%23.4538.6%$21.38m
SCMPSucampo Pharmaceuticals, Inc. Class A
-1.45%10.2014.4%$5.28m
AKTXAkari Therapeutics Plc Sponsored ADR
-29.69%4.502.2%$4.79m
EPIXESSA Pharma Inc
-0.83%0.290.0%$0.03m

Company Profile

Kitov Pharmaceuticals Holdings Ltd. in the research and development of combinations of existing drugs in advanced stages of development. The company focused on the development of therapeutic candidates for the simultaneous treatment of two clinical conditions: pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for osteoarthritis. Kitov Pharmaceuticals Holdings was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.